Precigen Inc (NASDAQ: PGEN) is -29.00% lower on its value in year-to-date trading and has touched a low of $0.79 and a high of $1.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PGEN stock was last observed hovering at around $0.90 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $0.95, the stock is 8.12% and 2.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing 6.29% at the moment leaves the stock -27.66% off its SMA200. PGEN registered -27.37% loss for a year compared to 6-month loss of -26.25%. The firm has a 50-day simple moving average (SMA 50) of $0.9354 and a 200-day simple moving average (SMA200) of $1.31765.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.93% gain in the last 1 month and extending the period to 3 months gives it a -13.51%, and is 20.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.99% over the week and 6.10% over the month.
Precigen Inc (PGEN) has around 202 employees, a market worth around $273.73M and $4.39M in sales. Profit margin for the company is -3084.55%. Distance from 52-week low is 20.71% and -50.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-280.63%).
Precigen Inc quarterly earnings per share for the current quarter are estimated at -0.08 with sales reaching $1.25M over the same period.The EPS is expected to shrink by -16.75% this year, but quarterly earnings will post -34.10% year-over-year. Quarterly sales are estimated to shrink -9.40% in year-over-year returns.
181.0 institutions hold shares in Precigen Inc (PGEN), with institutional investors hold 70.02% of the company’s shares. The shares outstanding are 248.92M, and float is at 142.55M with Short Float at 10.78%. Institutions hold 62.90% of the Float.
The top institutional shareholder in the company is PATIENT CAPITAL MANAGEMENT, LLC with over 18.17 million shares valued at $28.72 million. The investor’s holdings represent 7.2926 of the PGEN Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 10.25 million shares valued at $16.19 million to account for 4.1116 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 6.76 million shares representing 2.7122 and valued at over $10.68 million, while GEODE CAPITAL MANAGEMENT, LLC holds 1.2425 of the shares totaling 3.1 million with a market value of $4.89 million.
Precigen Inc (PGEN) Insider Activity
The most recent transaction is an insider purchase by Perez Jeffrey Thomas, the company’s SVP, IP Affairs. SEC filings show that Perez Jeffrey Thomas bought 58,823 shares of the company’s common stock on Aug 09 ’24 at a price of $0.85 per share for a total of $50000.0. Following the purchase, the insider now owns 0.74 million shares.
Precigen Inc disclosed in a document filed with the SEC on Aug 09 ’24 that KIRK RANDAL J (Director) bought a total of 23,529,411 shares of the company’s common stock. The trade occurred on Aug 09 ’24 and was made at $0.85 per share for $20.0 million. Following the transaction, the insider now directly holds 64.55 million shares of the PGEN stock.
Still, SEC filings show that on Dec 28 ’23, KIRK RANDAL J (Director) acquired 96,686 shares at an average price of $1.41 for $0.14 million. The insider now directly holds 1,096,686 shares of Precigen Inc (PGEN).
